Damn right! XKEM is the next massive OTC runner. Market cap is still way too low for the potential of this ONE DRUG. XKEM could easily sustain a 9 figure cap IMO on this news alone. Over 35 employees tells me this isn't your 2 man OTC pump.
Then add the cancer drug that Bristol Meyers tried keeping off the market and lost a lawsuit to XKEM for.
XKEM's cancer drug isn't being talked up and it has 50X the potential being a generic equivalent to BM's multi Billion dollar drug.
XKEM could see .25+ IMO. The momo is STRONG and the news has not even hit the wires yet. Very few know of the news, only those following closely.
We know it's coming. Buy before the masses.
My posting contains many opinions. So please do your own research and validation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.